1.Association between vaccination status and the incidence of breakthrough COVID-19 infections among University of Santo Tomas – Faculty of Medicine and Surgery students: A case-control study.
Ryan Irvin M. ABUSTAN ; Joaquin V. ABUNDANCIA ; Vincent Rhey L. ACCAD ; Kimberly Mae H. ADVINCULA ; Jillian Elize F. AFABLE ; Vanessa Joy A. AGRAVIADOR ; Ida Marie TABANGAY-LIM
Journal of Medicine University of Santo Tomas 2025;9(S1):75-83
INTRODUCTION
With the introduction of COVID-19 vaccines, schools around the world have slowly started to reimplement on-site classes with guidelines to prevent outbreaks. The University of Santo Tomas has devised their own set of guidelines, including safety protocols, vaccinations and daily health declarations. These were monitored using the
Thomasian Online Medical Services and Support (ThOMedSS).
Through a case-control study design, the study aims to determine an association between the vaccination status of UST Faculty of Medicine and Surgery (UST-FMS) students and breakthrough COVID-19 infections in the first semester of the academic year 2022-2023, with population data acquired via records of students participating in face-to-face classes from the UST Health Service Office, and categorized based on breakthrough infections and vaccination status.
STATISTICAL ANALYSISResults were analyzed using Pearson’s chi-square test and Fisher’s exact test (pCONCLUSION
The study suggests that vaccination status did not have a statistically significant association (p = 0.3451) with breakthrough infections. The majority (99.94%) of students have received the complete primary COVID-19 vaccination series and only 6.61% of this population developed breakthrough COVID-19 infections, all occurring in those completely vaccinated. Breakthrough infections were 1.76 times more likely for those with booster shots than those without. The possible reason for this is the emergence of the Omicron variant. To improve the study, external exposures and individual behaviors must be considered as potential factors influencing infection rates.
Human ; Male ; Female ; Child: 6-12 Yrs Old ; Adolescent: 13-18 Yrs Old ; Young Adult: 19-24 Yrs Old ; Association ; Case-control Studies ; Covid-19 ; General Surgery ; Faculty ; Incidence ; Infections ; Medicine ; Universities ; Vaccination
2.Awareness and possible treatment options toward COVID-19 among selected healthcare professionals in National Capital Region
Florence C. Navidad ; John Marlon P. Ancheta ; Joaquin V. Abundancia ; Angela Marie R. Ambal ; Ron Lemuel M. Brusola ; Josh Rogel L. Capco ; Julio Rafael Castillo ; Franzia Ellaine F. Castro
Philippine Journal of Health Research and Development 2022;26(1):33-41
Background:
Since December 2019, SARS-CoV-2, otherwise known as coronavirus disease 2019 (COVID-19), has caused worldwide panic and is now a serious problem. As the situation worsens, the need for an official cure becomes more crucial and different methods are being considered for treating infected COVID-19 patients.
Objectives:
This study aimed to emphasize and further elaborate on the existing and possible treatment methods against COVID-19 and assess the awareness of healthcare professionals (doctors, medical technologists, and nurses) on the treatments for COVID-19.
Methodology:
The study utilized an exploratory sequential mixed methods design following the treatment and misinformation theories models. The respondents were selected based on inclusion and exclusion criteria and recruited through the snowball sampling technique. The study used an adapted survey questionnaire on the pathophysiology of COVID-19 and possible treatment options. Descriptive statistical analysis for quantitative data and open thematic coding is used in an online qualitative deductive data analysis.
Results:
Based on the data, webinars, lectures, and discussions were the primary source of information among healthcare professionals. Most of the respondents showed proficiency with remdesivir among investigational selective medicines. Chloroquine was the top choice among selected repurposed drugs. They were aware of the convalescent plasma therapy that uses antibodies from the blood plasma of recovered COVID-19 patients. They were not aware of the different herbal treatments used to treat COVID-19.
Conclusion
Hence, chloroquine (repurposed drug), remdesivir (investigational drug), and convalescent plasma (adjunctive therapy) are the most well-known treatments for COVID-19. Most of the respondents were aware of the action and side effects of chloroquine, remdesevir, and convalescent plasma therapy.
COVID-19
;
Drugs, Investigational
;
Herbal

Result Analysis
Print
Save
E-mail